SCARs Label Warning For OTC PPIs In US Starts With Perrigo’s 131 Omeprazole Product Options
Executive Summary
FDA approves warning for severe cutaneous adverse reactions on labeling for Perrigo's 131 20-mg omeprazole delayed-release tablet products across unflavored and cool mint or wild berry-mint options and 14-, 28- and 42-count packages.